October 7, 2025

Neogen Corporation (NEOG) Stock Analysis: Exploring a 36% Potential Upside in the Diagnostics & Research Sector

Investors keen on the healthcare sector’s diagnostics and research vertical will find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect, especially given its potential upside of 36.18%...

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A Closer Look at Its 19.51% Upside Potential

Investors looking to capitalize on growth within the healthcare sector should pay close attention to U.S. Physical Therapy, Inc. (NYSE: USPH). With a market cap of..

AtriCure, Inc. (ATRC) Stock Analysis: A Healthcare Innovator with a 43.97% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a leader in the medical instruments and supplies industry, is capturing investor attention with a compelling narrative of growth potential and innovation..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and Promising Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has captured investor attention in the healthcare sector, specifically within the drug manufacturers’ niche. Known for its branded and generic pharmaceutical..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 106% Potential Upside in the Biotechnology Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning name in the biotechnology sector, is capturing investor interest with its promising potential upside of 106.04%. This clinical-stage biotechnology..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking the 303% Potential Upside for Investors

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering biotechnology firm based in San Diego, California, has captured investor attention with a staggering potential upside of 303.16%. This promising..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating Challenges with Promising Biotech Innovations

In the vibrant and competitive landscape of biotechnology, Ascentage Pharma Group International (AAPG) has positioned itself as a significant player in the healthcare sector. With a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: A Healthcare Play with a 14.27% ROE

Pediatrix Medical Group, Inc. (MD), a key player in the healthcare sector, operates within the medical care facilities industry, providing essential specialized care for newborns, expectant..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 51.5% Revenue Growth Surge and Future Prospects

Kestra Medical Technologies, Ltd. (KMTS) is garnering attention in the healthcare sector, particularly within the Medical Instruments & Supplies industry. Based in Kirkland, Washington, this U.S.-based..

MoonLake Immunotherapeutics (MLTX) Investor Outlook: A 167% Upside Potential in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a rising star in the biotechnology sector, has captured investor attention with its promising pipeline of therapies targeting inflammatory skin and joint..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomic Pioneer with a 2.96% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the Diagnostics & Research sector, is capturing attention with its robust 45.60% revenue growth and a market..

UFP Technologies, Inc. (UFPT): Investor Outlook Reveals 63% Potential Upside in Healthcare Innovator

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the attention of investors with its..

Amedisys Inc (AMED) Stock Analysis: Understanding the Growth Potential in the Healthcare Sector

Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, continues to capture investor interest with its strong focus on home health services, hospice care,..

Veracyte, Inc. (VCYT) Stock Analysis: 11.33% Potential Upside Amid Robust Diagnostic Innovations

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specializes in groundbreaking diagnostic solutions that span multiple types of cancer. With a market capitalization of..

Alvotech (ALVO) Stock Analysis: Healthcare Innovator with Over 100% Potential Upside

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, continues to pique investor interest with its innovative approach to biosimilar medicines and a remarkable potential upside. Operating in..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring an 86% Potential Upside for Investors

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its promising position..

Arcellx, Inc. (ACLX) Stock Analysis: Potential 34% Upside as Immunotherapy Innovations Advance

Arcellx, Inc. (NASDAQ: ACLX), a pioneering biotechnology firm based in Redwood City, California, is making significant strides in the healthcare sector with its innovative immunotherapy developments...

Amneal Pharmaceuticals, Inc. (AMRX) Rating Update: Analysts See 18.48% Upside Potential

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), a prominent player in the healthcare sector, is drawing attention from investors with a robust market capitalization of $3.31 billion. The..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 11.68% Potential Upside Amid Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a prominent player in the biotech sector, is drawing investor attention with its promising therapeutic pipeline and a market cap of..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Biotech Star with 37.50% Upside Potential

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector as a promising player with a focus on rare kidney and metabolic diseases. With a..

Search

Funds

October 7, 2025

Search

Funds

October 7, 2025

FTSE 100

Funds